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Abstract
Background: To control and manipulate cellular signaling, we need to understand cellular strategies for information
transfer, integration, and decision-making. A key feature of signal transduction is the generation of only a few intracellular
messengers by many extracellular stimuli.
Methodology/Principal Findings: Here we model molecular cross-talk between two classic second messengers, cyclic AMP
(cAMP) and calcium, and show that the dynamical complexity of the response of both messengers increases substantially
through their interaction. In our model of a non-excitable cell, both cAMP and calcium concentrations can oscillate. If
mutually inhibitory, cross-talk between the two second messengers can increase the range of agonist concentrations for
which oscillations occur. If mutually activating, cross-talk decreases the oscillation range, but can generate ‘bursting’
oscillations of calcium and may enable better filtering of noise.
Conclusion: We postulate that this increased dynamical complexity allows the cell to encode more information, particularly
if both second messengers encode signals. In their native environments, it is unlikely that cells are exposed to one stimulus
at a time, and cross-talk may help generate sufficiently complex responses to allow the cell to discriminate between
different combinations and concentrations of extracellular agonists.
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Introduction
Intracellular signaling is complex. Few signaling pathways act in
isolation, and the coordination of signal transduction is driven by
interactions between pathways. Determining the design principles
behind this complexity is necessary for understanding and
manipulating cellular activity [1]. Cells are unlikely to be exposed
to agonists individually, but probably simultaneously receive many
extracellular stimuli. We believe that interactions between
signaling pathways, so called molecular cross-talk, enables the cell
to process and interpret multiple inputs differently in different
contexts. For example, a cell exposed to two agonists, each
fostering a mutually exclusive response such as growth or
apoptosis, must ‘decide’ which signal to follow. Biochemically,
this decision is likely to occur with one pathway interacting with
and shutting down the activity of the other. In contrast, two weak
growth signals detected simultaneously could collectively have an
enhanced or synergistic effect, with each pathway reinforcing
signaling through the other.
Here we study the effects of cross-talk, or inter-pathway
interactions, between two classic second messenger pathways:
cAMP and intracellular calcium. Intracellular concentrations of
both are modified by the activation of multiple types of receptors,
many of which transduce their signals through heterotrimeric G
proteins – at the simplest level, Gs and Gi for cAMP and Gq for
calcium. Concentrations of cAMP are expected to increase or
decrease in response to the detection of an appropriate agonist.
Intracellular calcium concentrations can behave similarly, but can
also oscillate with a frequency that increases with the concentra-
tion of the agonist.
Using mathematical modeling, we investigated whether experi-
mentallydemonstrated interactionsbetweenthe cAMP and calcium
responses in non-excitable cells could substantially increase the
complexity of the dynamics of their joint response. A gain in
complexity increases the potential of the response to encode
information relevant to the extracellular environment and so alter
decisions affecting cellular behavior. The interaction between
calcium and cAMP signals has long been predicted to generate
oscillations in cAMP concentrations [2,3]. Such oscillations have
been measured in neurons and agree with simulations using models
of excitable cells [4,5]. Although cross-talk between different
calcium pathways has been investigated [6], the effects of multiple
simultaneous stimuli and of cross-talk between different second
messengershasbeen little studied,particularlyinnon-excitablecells.
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the binding of agonist to a G protein-coupled receptor (GPCR)
that can activate Gq. Agonist binding causes the activation of Gq
by promoting the exchange of GDP by GTP on the a subunit.
Activated Gq interacts with and activates phospholipase Cb
(PLCb) which, when activated, cleaves the membrane phospho-
lipid phosphatidylinositol 4,5-biphosphate (PIP2). This cleavage
generates 1,2-diacylglycerol (DAG), which remains at the mem-
brane, and inositol 1,4,5-trisphosphate (IP3), which diffuses into
the cytosol (Fig. 1a and 1b). By binding to IP3-sensitive calcium
channels in the endoplasmic reticulum (ER), IP3 causes the release
of calcium from intracellular stores. Among other events, the rise
in cytosolic calcium activates classical isoforms of protein kinase C
(PKC) which move from the cytosol to the membrane where they
can be further activated by DAG. Calcium release often leads to
further release of calcium and to calcium oscillations. In our
model, calcium oscillations are generated by negative feedback –
high concentrations of cytosolic calcium inhibit the release of
calcium by IP3 receptors – but positive feedback also occurs
because cytosolic calcium increases the rate at which PLCb
catalyzes the production of IP3.
The concentration of cytosolic cAMP increases through the
binding of agonist to GPCRs that activate Gs. Activated Gs
interacts with and activates different isoforms of adenylyl cyclase
(AC). Activated AC converts ATP to cAMP and pyrophosphate
(Fig. 1a and 1c). As cytosolic cAMP concentrations rise, cAMP
binds cooperatively to the two regulatory domains of protein
kinase A (PKA) causing the release of its two catalytic subunits
(Fig. 1d). PKA further transduces cAMP by phosphorylating many
specific target proteins.
We modeled the interactions between cAMP and calcium using
non-linear differential equations (Methods). Our model is generic
and therefore could form the basis of models for many different
cell types and signaling pathways. We focus on predicting
qualitative consequences from interactions between cAMP and
calcium signaling. Many different types of activated GPCRs can
lead to the activation of PLCb or AC. We wish to focus on the
potential effects of several agonists present simultaneously and,
rather than describe the activation of each type of receptor,
consider the concentrations of activated PLCb and AC as inputs to
our model because it is at these enzymes that the different
pathways first converge. Although we expect our results to be
qualitatively correct, we do not expect to be able to make
quantitative comparisons with experimental data without further
specializing the model.
The calcium and cAMP pathways are known to interact with
each other in a variety of different ways and cell types. Calcium can
influence cAMP signaling directly through modulating the activity
Figure 1. A schematic of the Gs, or cAMP, and Gq, or calcium, pathways. a Agonist (the triangle) binding to receptor activates a G
protein, G, which in turn activates an effector protein, E. For simplicity, the G protein is always bound to the receptor, and we show explicitly
neither Ga and Gbc nor the deactivation of the G protein. b The Gq pathway. The effector protein is the b isoform of phospholipase C. When activated,
PLCb cleaves the phospholipid PIP2 into membrane-bound DAG and cytosolic IP3. High IP3 concentrations cause the release of calcium ions from the
endoplasmic reticulum. PKC when bound by calcium is recruited to the membrane by DAG and becomes activated. c The Gs pathway. The effector
protein is adenylyl cyclase which synthesizes cAMP from ATP when activated. d The increased concentrations of cytosolic cAMP activate PKA by
binding to its inhibitory domain.
doi:10.1371/journal.pone.0007189.g001
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through PKC: PKC can phosphorylate and so desensitize Gs-
coupledreceptors[8],and PKCcaninteractwith someACisoforms
to enhance their enzymatic activity and increase cytosolic cAMP
[9]. Alternatively, cAMP can influence calcium signaling through
PKA: PKA can sensitize IP3 receptors on the ER increasing the
release of calcium into the cytosol [10,11], PKA can increase the
activity of calcium ATPases which pump calcium back into the ER
[12], PKA can phosphorylate and modulate the activity of receptors
coupled to both Gq and Gi [13], and PKA can phosphorylate and
inhibit PLCb [10,14,15,16,17,18]. In addition, elevated cAMP can
activate a novel PLC isoform [19], and some GPCRs activate G
proteins whose Ga sub-unit modulates AC, butwhose Gbc sub-units
modulate PLCb and vice versa [20].
For simplicity, we let calcium affect cAMP concentrations
through the action of PKC and let cAMP affect calcium
concentrations through the action of PKA. We will consider
mutual inhibition, with each pathway inhibiting the other, or
mutual activation, with each pathway activating the other. We
expect each the nature of the cross-talk to vary between cell types.
We will often use bifurcation diagrams to display qualitative
changes in the dynamics of cytosolic calcium as the stimuli to
either the calcium or cAMP pathways change. A bifurcation
diagram shows the changes in the long-time dynamics of a system
as a parameter of the system varies. For example, we will show the
dynamics of calcium as a function of the concentration of activity
of PLCb (Fig. 2a). If calcium reaches a steady-state concentration
for a range of concentrations of activated PLCb, we show these
steady-states as a thin line on the bifurcation diagram, with PLCb
concentrations plotted on the x-axis. If the system is bistable for a
range of concentrations of PLCb, two distinct calcium concentra-
tions are possible at steady-state and the particular concentration
reached depends on the condition of the system when the agonist
is applied. We show these two concentrations as two thin lines that
exist for the same range of PLCb concentrations. We indicate an
unstable steady-state, which the system can never reach, as a thin
dashed line. If calcium oscillates for a range of concentrations of
PLCb, we use two thick lines, one for the maximum and one for
the minimum concentration of calcium reached during one
oscillation. Concentrations of PLCb at which there is a transition
between two qualitatively different dynamical behaviors, such as
steady-state and oscillatory dynamics, are called bifurcation points.
Bifurcation diagrams thus succinctly display the general behavior
of a dynamical system [21,22]. We do not expect the form of the
bifurcation diagram to alter for small changes in the parameters of
the model.
Results
Individual pathways with no cross-talk
The dynamics of intracellular calcium are characterized by
oscillations (Fig. 2a). Calcium oscillations are generated by delayed
negative feedback: high concentrations of cytosolic calcium inhibit
calcium release through IP3 receptors on the ER [23]. Oscillations
occur when the concentration of agonists is within a range that
corresponds to specific concentrations of activated PLCb. Weak
stimuli do not produce enough IP3 to cause sufficient calcium
release from the IP3 receptors; strong stimuli result in high
cytosolic calcium concentrations and inhibit IP3 receptors. For
intermediate stimuli, the frequency of calcium oscillations
increases monotonically as the concentration of the input to the
pathway increases.
For activated PLCb of around 1.1 mM and higher, the system
can either tend to a steady-state, with a constant concentration of
calcium, or undergo oscillations in the concentration of calcium:
there is a bistability between a steady-state and a limit cycle. The
particular dynamics will depend on the initial state of the system
when the agonist was applied. Once activated PLCb concentra-
tions are high enough, this bistability disappears, and large
amplitude oscillations of calcium are lost near the bifurcation point
(Fig. 2a): the system tends once again to steady-state.
The dynamics of intracellular cAMP are characterized by
steady-states. As the concentration of agonists promoting cAMP
production increases so do concentrations of cytosolic cAMP and
activated PKA. cAMP concentrations do not oscillate (Fig. 2b).
Inter-pathway interactions and cross-talk
Interactions between cAMP and calcium signaling can: (i) cause
oscillations in both second messengers; (ii) create a bistability
between two steady-states; and (iii) generate oscillations with
complex waveforms, so-called ‘bursting’ oscillations, through
period-doubling bifurcations.
Negative or mutually inhibitory interactions at least double the
range of concentrations of activated PLCb that can generate
calcium oscillations (Fig. 3a and 3b). However, they can also
prevent oscillations for concentrations of activated PLCb that
would normally generate oscillations in the absence of molecular
cross-talk. Thus such interactions modulate the sensitivity of the
system. The onset and offset concentrations of activated PLCb at
which oscillations start and stop are increasing functions of
activated AC, but the offset concentrations increase more rapidly,
and the range of activated PLCb generating oscillations widens.
Oscillations in calcium are transmitted to oscillations in cAMP,
whose oscillations in turn modulate those of calcium. Conse-
quently, both second messengers oscillate with the same frequency.
At low frequencies, cAMP oscillations are approximately synchro-
nized with calcium oscillations (Fig. 3a), but at higher frequencies
there is a significant phase lag (Fig. 3a). The amplitudes of both
oscillations are different and change with changes in the stimuli to
the system (Fig. 3c and Fig. 3d).
Negative interactions broaden the range of concentrations of
activated PLCb for which calcium oscillations are dominated by a
particular frequency (Fig. 3b). Consequently, if we consider
signaling only through the frequency of calcium oscillations,
negative interactions and exposure to cAMP-generating ligands
increases the robustness of signaling to fluctuations in the activity
and concentrations of upstream components.
The bifurcation diagram (Fig. 3a) is similar to the bifurcation
diagram for calcium signaling in the absence of molecular cross-talk
(Fig. 2a). As concentrations of activated PLCb increase, the system
passes from a stable steady-state (constant calcium concentrations)
to a stable limit cycle (oscillating calcium concentrations) and then
bifurcates again to another stable steady-state. There is also,
however, a bistability not present in Fig. 2a. For concentrations of
activated PLCb near 1 mM, two stable steady-states co-exist (Fig. 3a
and 3b): one has high concentrations of cytosolic calcium of around
1 mM, corresponding to strong activation of PKC and more modest
activation of PKA, and the other has low concentrations of cytosolic
calcium and corresponds to reduced activation of PKC and more
strong activation of PKA. For two mutually exclusive sets of initial
conditions, the system will tend to one of these steady-states if the
concentration of activated PLCb lies in the bistable region.
With positive or mutually activating inter-pathway interactions,
the range of activated PLCb that generates calcium oscillations
decreases and more complex oscillations can occur through
period-doubling bifurcations (Fig. 4a and 4b). cAMP oscillates
with the same frequency as the concentration of calcium (Fig. 4c
and 4d) and tends to phase lag at higher frequencies. As
Cross-Talk and Signaling
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cytosolic calcium reaches a steady-state, then undergoes oscilla-
tions which can bifurcate into ‘bursting’ oscillations before again
reaching another steady-state at higher concentrations of activated
PLCb where, contrary to the non-interacting case, the amplitude
of the oscillations steadily decrease to zero (Fig. 4a). Increasing
concentrations of AC increase the sensitivity to calcium by
reducing the concentration of activated PLCb at which oscillations
start. The positive interactions not only ‘prime’ the system for
release of calcium from the ER, but also allow inhibition of IP3
receptors to occur at lower concentrations of activated PLCb by
promoting higher cytosolic calcium concentrations. The higher
concentrations of IP3 created by positive interactions can cause
calcium to be released from the ER in burst-like oscillations. These
bursts generate two or more substantial peaks to the waveform of
the calcium oscillations (Fig. 4a).
Bursting oscillations in the concentration of calcium have been
observed in hepatocytes in response to elevated cytosolic cAMP
concentrations and to stimulation by some agonists [24]. Several
mechanisms for the generation of such oscillations have been
proposed, and all have focused on interactions within the calcium
pathway [25,26,27,28,29]. Although our model is generic and
is not intended to accurately describe a hepatocyte per se, it
indicates that positive interactions with a background level of
activity of the cAMP pathway is another possible explanation of
these observations.
Figure 2. The dynamics of the Gq pathway (upper panels) and the Gs pathway (lower panels). a A bifurcation diagram for the Gq pathway
showing the nature of the calcium response for differing concentrations of activated PLCb. Thin lines indicate a stable steady-state concentration of
calcium; thick lines indicate that calcium concentrations oscillate. The upper thick line marks the maximum concentration that calcium reaches during
one oscillation; the lower thick line marks the minimum concentration reached. Dotted lines indicate unstable attractors and red squares show
bifurcation points. The label HB indicates a Hopf bifurcation; LP indicates a saddle-node bifurcation. The frequency of calcium oscillations ranges from
effectively zero Hz when the concentration of PKCb is near 0.65 mM and to approximately 0.12 Hz (a period of around 8 s) when the concentration of
PKCb is near 2.4 mM. Example time courses of calcium concentration illustrating the appearance and disappearance of oscillations are shown at
different points in the bifurcation diagram: at activated PLCb concentrations of 0.3 mM, 0.9 mM, 2.0 mM, and 2.5 mM. b A bifurcation diagram for the
Gs pathway showing stable steady-state concentrations of activated PKA for differing concentrations of activated AC. cAMP concentrations behave
similarly and appear linear for the AC concentrations shown. In the example time course at 0.15 mM concentration of activated AC, activated PKA
increases monotonically with time while agonists are present. The concentration of cAMP behaves similarly.
doi:10.1371/journal.pone.0007189.g002
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better filter fluctuations in agonist concentrations. The same
frequency of calcium oscillations can be achieved by a high
concentrations of agonist for Gq-coupled receptors for the non-
interacting system or by low concentrations of agonist for both Gq-
and Gs-coupled receptors when the pathways interact (Fig. 4b). If
the mean concentration of input agonist is low, fluctuations could
still drive concentrations of activated PLCb high enough to cause
temporary, erroneous activation of downstream proteins. By
allowing the frequency of calcium oscillations to encode the
presence of two signals, positive inter-pathway interactions reduce
such erroneous signaling because the two agonists will rarely both
fluctuate simultaneously to high concentrations, even though low
levels of agonist are more stochastic. For example, standard
simulation techniques show that two stochastic processes with
mean m, say, both simultaneously cross an arbitrary threshold of
3m=2 one third less often than a stochastic process with a mean
twice as large (2m) crosses a threshold that is also twice as large
(3m), even though the process with mean 2m fluctuates less
strongly than the process with mean m (its coefficient of variation is
reduced by approximately 30%).
Discussion
We have shown that interactions between signaling pathways
with different second messengers can generate dynamics similar to
those seen in neurons [4] in a generic model of a non-excitable
cell, and both cell types may have similar information processing
capabilities. Cross-talk can generate cAMP oscillations with the
same frequency as calcium oscillations. Such inter-dependent
cAMP and calcium oscillations have been observed in non-
excitable cells, both in pancreatic b cells [30,31] and in human
embryonic kidney cells [32]. Information can be encoded in the
amplitude, phase, waveform, and frequency of these oscillations
[33], both for cAMP and calcium. Signaling through oscillations
rather than through changes in concentrations at steady-state may
provide other advantages for the cell [3,23]. Information transfer
may be less susceptible to corruption by stochastic effects [34].
Oscillations can also enhance signaling efficiency: signals with a
mean concentration at steady-state below the threshold of
activation of a downstream component might still activate that
component if the signals oscillate sufficiently often above threshold
[35], and desensitization to stronger input stimuli and large,
potentially energetically wasteful, transitions in concentration are
both avoided [3].
Within our model cross-talk leads to a number of qualitative
experimental predictions. By responding to concentrations of both
activated AC and PLCb, the system gains an extra degree of
freedom, with changes to either stimuli generating the same
response. For example, decreasing the frequency of cAMP
oscillations in Fig. 3b could be achieved by either decreasing the
stimulus to the Gq pathway while maintaining the Gs stimulus or
by decreasing the stimulus to the Gs pathway while maintaining
the Gq stimulus. We also predict a new region of bistability if inter-
pathway interactions are negative (Fig. 3a). For concentrations of
activated PLCb near 1.5 mM, the system can act like a toggle
Figure 3. The response of the system with negative or mutually inhibiting interactions between cAMP and calcium. a A bifurcation
diagram for calcium as a function of activated PLCb when activated AC is at 0.25 mM. Symbols are the same as Fig. 2. Example time courses show
oscillations in both calcium and cAMP when activated PLCb is at 2.1 mM or 4.5 mM. The frequency of the oscillations increases with activated PLCb
and a phase lag appears between cAMP and calcium. b The frequency of the cAMP and calcium oscillations as a function of both activated AC and
PLCb concentrations. A region where the system has two stable steady-states is shaded black. c The amplitude of the calcium oscillations for the
same range of activated AC and PLCb. d The amplitude of the cAMP oscillations. We model only global levels of second messengers. Local changes at
distinct sub-cellular sites may be much higher.
doi:10.1371/journal.pone.0007189.g003
Cross-Talk and Signaling
PLoS ONE | www.plosone.org 5 October 2009 | Volume 4 | Issue 10 | e7189switch. Two steady-state concentrations of calcium are possible –
one close to zero and the other near 1 mM – and we predict
hysteretic, or history-dependent, behavior with the flipping of the
switch occurring at different concentrations of activated PLCb
when the concentration of agonists to the Gq pathway changes
from high to low than when it changes from low to high (the
stimuli to the Gs pathway remain unchanged). For a much larger
region of activated PLCb or Gq agonist concentrations, there is
bistability between a steady-state and an oscillatory response
(Fig. 3e), similar to the one present in the Gq pathway alone. The
system can act like an alarm, where a sufficiently large
perturbation, for example a change in the concentration of
calcium or cAMP, can cause a substantial change in dynamics
which will persist once the perturbation has receded. A large
perturbation can cause a system with a constant concentration of
calcium to begin oscillating with an amplitude of several times the
concentration of calcium at steady-state. Similarly, in the bistable
region, a system with oscillating calcium and cAMP concentra-
tions can be perturbed in such a way that both oscillations
permanently stop.
We have focused on describing the generic behavior generated
by cross-talk between the Gq and Gs pathways and would expect
to adapt our model to describe a particular cell type. Parameters
and concentrations of enzymes and receptors will change, but
different cell types may also implement cross-talk with different
biochemistry or perhaps cross-talk only from one pathway
to another and not mutually between both pathways. It is
unfortunately experimentally challenging to determine the mech-
anism generating any detected cross-talk.
Cells are rarely exposed to one stimuli at a time, and yet many
signaling pathways converge on only a few second messengers.
Considering individual signaling pathways, it is puzzling to
understand cAMP and calcium responses and how cells
distinguish between different environments characterized by
differing combinations of stimuli. For a receptor that activates
synthesis of cAMP, steady-state concentrations of cAMP grow
monotonically with increased amounts of agonist (Fig. 2b), but
will fluctuate because of the inevitable stochasticity present in
any biochemical process [36]. From an information theoretic
perspective, such a cAMP response may therefore encode little
information [37]: with large fluctuations in cAMP, the cell can
potentially only discriminate between a concentration of agonist
above or below a threshold concentration. Information from
concentrations of agonists that change with time, for example in
pulses, may be lost. In contrast, receptors that upon binding of
agonist increase intracellular concentrations of calcium can cause
oscillations in intracellular calcium and so potentially encode
more information [33]. For calcium signaling to transmit
information at its full capacity without its more complex time-
dependent response being redundant, the input agonist concen-
tration must itself have complex time-dependent behavior.
Typically, however, agonist concentrations do not: some oscillate
but many change from one steady-state concentration to a new
higher or lower concentration.
Figure 4. The response of the system with positive or mutually activating interactions between cAMP and calcium. a A bifurcation
diagram for calcium as a function of activated PLCb when activated AC is at 0.17 mM. Symbols are the same as Fig. 2. PD indicates a period-doubling
bifurcation. Example time courses of calcium and cAMP are shown when activated PLCb is at 0.2 mM, 0.28 mM, 0.31 mM, and 0.36 mM. Bursting
oscillations appear for intermediate activated PLCb concentrations. The amplitude of the oscillations increases and decreases as activated PLCb
increases, and oscillations gradually disappear. b The frequency of the cAMP and calcium oscillations as a function of both activated AC and PLCb
concentrations. c The amplitude of the calcium oscillations. d The amplitude of the cAMP oscillations.
doi:10.1371/journal.pone.0007189.g004
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understood. A network with inter-pathway cross-talk presumably
simultaneously detects multiple signals. The information content
of the stimulus to such a signaling network increases substantially.
In the simplest scenario, when an agonist concentration is
classified only as high or low (by being above or below a threshold
concentration), the information content of an input signal of n
agonists can be n times that of a single agonist [38]. The network’s
potential to encode information also grows if both cAMP and
calcium respond to this signal, particularly because cross-talk
increases the dynamical complexity of their response. The cell, in
turn, will have more potential to discriminate between different
stimuli.
Intracellular calcium with its complex dynamics may provide
cells with enough information content to allow discrimination
between multiple agonists on its own. Indeed in some cells no
evidence of interaction between cAMP and calcium has been
found. We would predict that such cells have relatively few types of
receptors that activate cAMP or calcium signaling or that such
receptors are sequestered in some way to isolate their activity. In
general, many agonists modify concentrations of cAMP, and we
might therefore expect concentrations of cAMP to also have
complex dynamics without any interactions with calcium. The
cellular machinery that generates calcium oscillations is elaborate,
involving intracellular stores of calcium, shuttling of molecules to
and from the plasma membrane, and complex gating schemes of
calcium channels. Perhaps rather than create new machinery to
generate cAMP oscillations, the pre-existing calcium oscillator
may have better served evolution.
For a cell to be able to discriminate between different
combinations of stimuli, its response must occur in such a way
that the responses from different types of receptors are coordinated
and must be of sufficient complexity to encode enough
information to allow the discrimination. We postulate that by
having many pathways converge on a small number of second
messengers, communication occurs between different receptors
and have shown here that cross-talk between second messengers
potentially generates sufficient complexity in cellular responses to
allow discrimination, at least between some combinations of
stimuli.
Methods
Although we consider regulation of both second messengers in
general, we will assume that cAMP concentrations are increased
through the action of Gs and that calcium concentrations are
increased through the action of Gq. Rather than explicitly model
activation of the G proteins, we will consider the concentrations of
activated enzymes directly downstream from the G proteins as the
inputs to the pathways.
Modeling calcium signaling
We use the concentration of activated PLCb as a measure of the
activity of the calcium signaling pathway, which is determined by
the total amount of agonists present that modify calcium signaling
through PLCb. These agonists may bind many different types of
GPCR. Our model of calcium signalling is based on that of Meyer
and Stryer [39]. Although we ignore several cellular fluxes of
calcium, the model generates the experimentally observed calcium
dynamics [40,41] and as such is appropriate for examining the
effects of cross-talk with other pathways.
Our model is a system of coupled non-linear differential
equations. We assume that the production of IP3 is stimulated by
activated PLCb whose activity is enhanced by calcium ions [42].
Letting IP3 ½  denote the concentration of IP3, PLC  ½  denote the
concentration of activated PLCb, and Ca ½  denote the cytosolic
concentration of calcium ions, we have
d
dt
IP3 ½  ~vi
Ca ½  PLC  ½ 
K
1 ðÞ
c z Ca ½ 
{bi IP3 ½  ð 1Þ
where bi is the turn-over rate of IP3, which we assume constant for
the time scale of interest; vi is the maximum rate of synthesis of IP3
by activated PLC; and K
1 ðÞ
c is the concentration of calcium ions at
which activated PLC synthesizes IP3 at half its maximum rate. We
do not explicitly model PIP2. Throughout, the K parameters are
constant and have units of concentration.
Cytosolic calcium is increased by the release of calcium from the
ER by IP3 receptors and is decreased by ATPases which pump
calcium back into the ER. We assume that the total amount of
intracellular calcium – the sum of cytosolic calcium and calcium in
the ER – is constant. Calcium is also involved in the activation of
PKC. Denoting the concentration of calcium in the ER by Ca ½  ER
and the concentration of activated PKC by PKC  ½  , the dynamics
of cytosolic calcium is described by
d
dt
½Ca ~ v(1)
c
½IP3 
Kiz½IP3 
   4
zv(2)
c
"#
½Ca ERhIP3R
{v(3)
c
½Ca 
2
(K
(2)
c )
2z½Ca 
2
 !
{
d
dt
½PKC  :
ð2Þ
The opening of IP3 receptors is highly cooperative [43], and we
use the Meyer and Stryer model with a Hill coefficient of four [23].
We also allow a small leakage current from the IP3 receptors [44]
denoted by v
2 ðÞ
c . The parameter v
1 ðÞ
c determines the maximum rate
that IP3 receptors can release calcium ions; Ki is determined by
the affinity of IP3 binding to the receptors; v
3 ðÞ
c is the maximum
rate of activity of the ATPases; and Kc is the concentration of
cytosolic calcium ions at which this rate is half-maximal [45]. The
fraction of active IP3 receptors decreases because of the negative
feedback caused by high cytosolic calcium concentrations. We
model this behavior through the variable hIP3R
d
dt
hIP3R~b4
r 1{hIP3R ðÞ { Ca ½ 
4hIP3R ð3Þ
whose steady-state value drops rapidly as a function of calcium
[44], and with br the concentration of calcium ions that makes
hIP3R half-maximal.
For the activation of PKC, DAG is necessary [46], and DAG
production depends on cleavage of PIP2 by PLCb, a process
enhanced by calcium:
d
dt
DAG ½  ~vi
Ca ½  PLC  ½ 
K
1 ðÞ
c z Ca ½ 
{bd DAG ½  {
d
dt
PKC  ½  : ð4Þ
We assume DAG turns over at a constant rate, bd, for the time
scales we study. We consider the activation of classic isoforms of
PKC which require binding to both DAG and calcium. By
assuming a fixed total concentration of cytosolic PKC and a two
step activation process – PKC first binding calcium and then DAG
with the binding of DAG the rate-limiting step, and consequently
Cross-Talk and Signaling
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we find that the concentration of activated PKC, [PKC ], satisfies
d
dt
PKC  ½  ~v 1 ðÞ
p
DAG ½  Ca ½ 
Kdz DAG ½ 
PKC ½  {v 2 ðÞ
p
PKC  ½ 
Kdz DAG ½ 
ð5Þ
which appears in Eqs. 2 and 4. Here Kd is the ratio of the rate of
calcium dissociating from PKC and the rate of DAG binding
calcium-bound PKC; v
1 ðÞ
p is the rate of calcium binding PKC; and
v
2 ðÞ
p is the product of Kd and the rate of dissociation of DAG when
bound to PKC.
Modeling cAMP signaling
We use the concentration of activated AC as a measure of the
activity of the cAMP signaling pathway. It is determined by the
total amount of agonists present that modify cAMP signaling
through AC. These agonists may bind many different types of
GPCR, and we do not explicitly model G protein activation.
PKA is activated by increasing concentrations of cytosolic
cAMP, denoted cAMP ½  . Activated AC (AC ) synthesizes cAMP
from ATP at a rate vm, where we assume a constant concentration
of cytosolic ATP. Cytosolic cAMP concentrations are constitu-
tively decreased by the enzyme cAMP phosphodiesterase, which
converts cAMP to 59-AMP. Denoting the concentration of
activated PKA by PKA  ½  , we consequently have that
d
dt
cAMP ½  ~vm AC  ½  {bm cAMP ½  {2
d
dt
PKA  ½  ð 6Þ
where we have included a constant concentration of phosphodi-
esterase in the rate bm. cAMP activates PKA by two molecules of
cAMP binding to a single PKA regulatory domain which is then
released. PKA is inactivated by the re-binding of free PKA
regulatory domains. If we assume a two step process for cAMP
binding PKA and that the binding of the second cAMP is rate-
limiting so that the intermediate state with just one cAMP bound is
at quasi-steady-state, then activated PKA satisfies
d
dt
PKA  ½  ~v 1 ðÞ
a
cAMP ½ 
2
Kaz cAMP ½ 
PKA ½  {v 2 ðÞ
a
PKA  ½ 
Kaz cAMP ½ 
ð7Þ
if the total concentration of cytosolic PKA does not change for the
time scales we study. Here Ka is the ratio of the first cAMP
dissociating from PKA and the rate of the second cAMP binding
to PKA; v
1 ðÞ
a is the rate of association of the first cAMP; and v
2 ðÞ
a is
the product of Ka and the rate of dissociation of the second cAMP
from PKA. Eq. 7 appears in Eq. 6.
Parameters
We give the values of the parameters we used in Table 1. We chose
some parameters to match an earlier model of calcium signalling [39]
(parameters bi,br,K
1 ðÞ
c ,K
2 ðÞ
c ,v
1 ðÞ
c ,v
2 ðÞ
c ,a n dv
3 ðÞ
c ). The remaining were
chosen to ensure that the concentration of cAMP was of the order of
0.120.01 mM and that PKA and PKC were sensitive to changes over
the entire range of concentrations of their upstream modulators when
the pathways were modelled alone (Fig. 2) or together. We used the
same parameters when modelling the individual pathways and the
negative and positive inter-pathway interactions.
Modeling molecular cross-talk
To model cross-talk between pathways, we assume that an
enzyme in one pathway is affected by the activity of the other
pathway. We let this enzyme be an allosteric protein with two
conformational states, one that strongly promotes signalling and
another that only weakly promotes signalling. A negative inter-
pathway interaction biases the enzyme to be predominantly in the
state that weakly promotes signalling; a positive inter-pathway
interaction biases the enzyme to be predominantly in the state that
strongly promotes signalling.
We allow PKA to either enhance or inhibit the net activity of
PLCb by altering its requirements for calcium ions. We model the
affect of PKA on PLCb by assuming PLCb to be allosterically
regulated and to have two conformational states, one whose activity
is strongly enhanced by calcium and one whose activity is only
weakly enhanced. PKA binds to and phosphorylates PLCb and can
enhance IP3 production by binding to the state whose activity is
strongly enhanced by calcium or can repress IP3 production by
binding to the state whose activity is weakly enhanced by calcium.
The affinity K
1 ðÞ
c in Eq. 1 and Eq. 4 then becomes
K 1 ðÞ  
c ~K 1 ðÞ
c zcs
PKA  ½ 
Ksz PKA  ½ 
   4
, ð8Þ
a function of PKA  ½  . We assume that PKA phosphorylates PLCb
processively on multiple phosphorylation sites and set a Hill
coefficient of four to describe their interaction. Decreasing or
increasing this Hill coefficient by one little changes the bifurcation
diagrams. The parameter Ks is determined by the affinity of
Table 1. Values used for the parameters in the model.
Parameter Value
bd 0.5 s{1
bi 2s {1
bm 0.15 s{1
br (0.02)
1
4 s{1
Ka 0.01 mM
K
1 ðÞ
c 1 mM
K
2 ðÞ
c 0.15 mM
Kd 0.2 mM
Ki 0.4 mM
Kq 0.003 mM
Ks 0.02 mM
v
1 ðÞ
a 1 mM{1 s{1
v
2 ðÞ
a 0.01 mMs {1
v
1 ðÞ
c 20 s{1
v
2 ðÞ
c 0.01 s{1
v
3 ðÞ
c 40 s{1
vi 2s {1
vm 0.1 s{1
v
1 ðÞ
p 1 mM{1 s{1
v
2 ðÞ
p 0.7 s{1
Initial Conditions Value
Ca ½  0.1 mM
CaER ½  1100 mM
PKC ½  1 mM
PKA ½  0.59 mM
doi:10.1371/journal.pone.0007189.t001
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we set csw0, typically to 1vcsv2; if PKA promotes the activity of
PLCb we set csv0, typically to {1. Different values of cs do not
qualitatively change the bifurcation behavior except that the
negative feedback has to be sufficiently strong (cs must be above
approximately 1) for the bistability between two steady-states to be
generated in Fig. 3a.
We allow PKC to enhance or inhibit the enzymatic activity of
AC by assuming AC is also an allosteric protein with an active and
an inactive state. PKC will bind preferentially to only one of these
states. Eq. 6 then becomes
d
dt
½cAMP ~vm½AC   1zcq
½PKC  
Kqz½PKC  
  
{bm½cAMP {2
d
dt
½PKA  
ð9Þ
where cqw0, typically cq~2, when PKC enhances cAMP
production by binding to the active state of AC and cqv0,
typically cq~{1, when PKC inhibits cAMP production by
binding to the inactive state. The parameter Kq is determined by
the affinity of activated PKC to AC.
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